Increased risk of volume overload with plasma compared with four‐factor prothrombin complex concentrate for urgent vitamin K antagonist reversal

類似資料

• Safety of a Four‐factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials
  著者:: Milling, Truman J., 等
  出版事項: (2016)
• Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding A Randomized, Plasma-Controlled, Phase IIIb Study
  著者:: Sarode, Ravi, 等
  出版事項: (2013)
• Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial
  著者:: Goldstein, Joshua N, 等
  出版事項: (2015)
• Thromboembolic Events After Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate: Exploratory Analyses of Two Randomized, Plasma-Controlled Studies
  著者:: Milling, Truman J., 等
  出版事項: (2015)
• Prothrombin complex concentrates for perioperative vitamin K antagonist and non vitamin K anticoagulant reversal
  著者:: Levy, Jerrold H, 等
  出版事項: (2018)